Critical Survey: Rallybio (NASDAQ:RLYB) versus Corvus Pharmaceuticals (NASDAQ:CRVS)
Rallybio (NASDAQ:RLYB – Get Free Report) and Corvus Pharmaceuticals (NASDAQ:CRVS – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, earnings, analyst recommendations, profitability and risk. Analyst Recommendations This is a summary of recent […]
More Stories
Analysts Set Alumis Inc. (NASDAQ:ALMS) Price Target at $27.50
Shares of Alumis Inc. (NASDAQ:ALMS – Get Free Report) have received an average recommendation of “Buy” from the eight analysts...
First Interstate BancSystem, Inc. (NASDAQ:FIBK) Receives $32.50 Consensus Target Price from Brokerages
Shares of First Interstate BancSystem, Inc. (NASDAQ:FIBK – Get Free Report) have earned an average recommendation of “Hold” from the...
StockNews.com Upgrades Thomson Reuters (NYSE:TRI) to “Hold”
StockNews.com upgraded shares of Thomson Reuters (NYSE:TRI – Free Report) (TSE:TRI) from a sell rating to a hold rating in...
Oak Woods Acquisition Co. (NASDAQ:OAKUW) Sees Significant Decline in Short Interest
Oak Woods Acquisition Co. (NASDAQ:OAKUW – Get Free Report) was the recipient of a significant drop in short interest in...
PIMCO Municipal Income Fund III (NYSE:PMX) Short Interest Down 24.4% in October
PIMCO Municipal Income Fund III (NYSE:PMX – Get Free Report) was the recipient of a large decrease in short interest...
Enstar Group Limited (NASDAQ:ESGRO) Short Interest Update
Enstar Group Limited (NASDAQ:ESGRO – Get Free Report) saw a large drop in short interest during the month of October....